Free Trial

Silexion Therapeutics (SLXN) SEC Filings & 10K Form

Silexion Therapeutics logo
$0.86 +0.02 (+2.57%)
Closing price 07/25/2025 03:59 PM Eastern
Extended Trading
$0.87 +0.00 (+0.28%)
As of 07/25/2025 07:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Silexion Therapeutics SEC Filings

DateFilerForm TypeView
07/21/2025
11:05 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form PRE 14A
07/16/2025
7:55 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/14/2025
3:05 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/09/2025
8:15 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2025
3:05 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K/A
07/08/2025
8:35 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/07/2025
8:29 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form DEFA14A
06/26/2025
3:15 PM
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
Wildcat Capital Management, LLC (Filed by)
Form SCHEDULE 13D/A
06/23/2025
3:48 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form DEFA14A
06/16/2025
9:51 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form DEF 14A
05/29/2025
11:15 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form EFFECT
05/29/2025
9:14 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/28/2025
3:04 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form POS AM
05/23/2025
4:00 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2025
8:20 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2025
4:01 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
05/13/2025
10:36 AM
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
Form SCHEDULE 13G/A
05/12/2025
11:12 AM
CVI Investments, Inc. (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
Form SCHEDULE 13G/A
05/06/2025
7:35 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
05/01/2025
11:15 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form EFFECT
04/29/2025
3:10 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form AW
04/29/2025
3:15 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form POS AM
04/29/2025
11:10 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
04/27/2025
11:15 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form EFFECT
04/23/2025
3:28 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form POS AM
04/23/2025
8:53 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2025
3:06 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form POS AM
04/10/2025
3:09 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form POS AM
04/01/2025
11:15 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form EFFECT
04/01/2025
3:45 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
03/28/2025
7:30 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2025
3:42 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/14/2025
6:27 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
03/14/2025
5:59 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/05/2025
7:46 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/10/2025
4:31 PM
GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
Form SCHEDULE 13G
01/30/2025
8:26 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2025
7:56 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2025
11:19 AM
CVI Investments, Inc. (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
Form SCHEDULE 13G
01/21/2025
4:49 PM
INTRACOASTAL CAPITAL, LLC (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
Form SCHEDULE 13G
01/17/2025
5:56 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
BREAKING: The House just passed 3 pro-crypto bills! (Ad)

Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the country are buzzing in anticipation

Click here to discover my #1 Coin To Own Right Now.
01/17/2025
5:44 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B4
01/15/2025
11:15 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form EFFECT
01/15/2025
5:02 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/14/2025
4:02 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form S-1/A
01/14/2025
5:19 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form S-1/A
01/14/2025
5:01 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
5:00 AM
Peled Amnon (Reporting)
Silexion Therapeutics (Issuer)
Silexion Therapeutics Corp (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
12/17/2024
6:08 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2024
5:01 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/10/2024
8:41 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
12/10/2024
8:42 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
12/10/2024
7:48 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/29/2024
5:00 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/29/2024
5:05 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
11/29/2024
5:06 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
11/27/2024
5:01 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2024
3:30 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2024
3:32 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
11/20/2024
5:15 AM
Guangzhou Sino-Israel Bio-Industry Investment Fund LLP (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
Form SC 13D
11/14/2024
8:03 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
7:30 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/01/2024
3:05 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
4:24 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form S-1
Registration statement under Securities Act of 1933  
10/22/2024
8:02 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form DEF 14A
10/16/2024
11:15 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form EFFECT
10/16/2024
8:32 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
10/10/2024
4:00 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form PRE 14A
10/09/2024
5:04 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form S-1
Registration statement under Securities Act of 1933  
10/01/2024
5:53 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/24/2024
6:10 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2024
3:05 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2024
3:06 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
09/18/2024
3:32 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 424B3
09/17/2024
11:15 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form EFFECT
09/09/2024
6:33 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form S-1
Registration statement under Securities Act of 1933  
09/09/2024
7:00 AM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/29/2024
3:48 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/22/2024
5:44 PM
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
Wildcat Capital Management, LLC (Filed by)
Form SC 13D
08/22/2024
4:23 PM
Moringa Sponsor, LP (Filed by)
Silexion Therapeutics (Subject)
Silexion Therapeutics Corp (Subject)
Form SC 13D
08/21/2024
3:45 PM
Silexion Therapeutics (Filer)
Silexion Therapeutics Corp (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/15/2024
6:38 PM
Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Lushi Avner (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2024
6:43 PM
Abramov Dror Yosef (Reporting)
Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2024
6:47 PM
Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Shiloah Ilan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2024
6:48 PM
Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Hadar Ilan (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2024
6:48 PM
Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Horenshtein Hadar Mirit (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2024
6:49 PM
Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Shirvan Mitchell (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2024
6:49 PM
Alon Ruth (Reporting)
Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2024
6:50 PM
Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Noy Shlomo (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2024
6:54 PM
Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Levin Ilan (Reporting)
Moringa Sponsor, LP (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/15/2024
7:12 PM
Silexion Therapeutics (Issuer)
Biomotion Sciences (Issuer)
Potter Leonard (Reporting)
Wildcat Capital Management, LLC (Reporting)
Wildcat Partner Holdings, LP (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
Trump’s #1 America First Stock (Ad)

America’s industrial comeback is underway — and it’s bigger than anyone expected. Over $5 trillion has already been pledged to restore U.S. manufacturing. Trump’s tariffs and trade pressure have set off a massive reshoring push, and the flood of investment is still gaining steam. But while everyone’s watching the big names, one under-the-radar company holds the key tech that could make it all work — and potentially benefit the most.

This could be the #1 America First stock of the decade.
08/15/2024
2:22 PM
Silexion Therapeutics (Filer)
Biomotion Sciences (Filer)
Form CERT
08/15/2024
1:45 PM
Silexion Therapeutics (Filer)
Biomotion Sciences (Filer)
Form 8-A12B
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SLXN) was last updated on 7/26/2025 by MarketBeat.com Staff
From Our Partners